Stifel Upgrades Zimmer Biomet (ZBH) to Buy
Stifel upgraded Zimmer Biomet (NYSE: ZBH) from Hold to Buy with a price target of $168.00 (from $120.00).Analyst Rick Wise ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
